London-based pharmaceutical company Senzer has entered administration, after failing to get enough backing to float on the Alternative Investment Market. Professional services firm Begbies Traynor has been appointed administrator of Senzer, which entered administration in early January. Senzer developed and manufactured respiratory devices for medical cannabis use. Its core product was a breath-activated inhaler that […]